Literature DB >> 26350408

Is multiple system atrophy with cerebellar ataxia (MSA-C) like spinocerebellar ataxia and multiple system atrophy with parkinsonism (MSA-P) like Parkinson's disease? - A saccade study on pathophysiology.

Yasuo Terao1, Hideki Fukuda2, Shinnichi Tokushige3, Satomi Inomata-Terada3, Akihiro Yugeta3, Masashi Hamada3, Yaeko Ichikawa4, Ritsuko Hanajima5, Yoshikazu Ugawa6.   

Abstract

OBJECTIVE: Patients with multiple system atrophy (MSA) are classified into those mainly manifesting cerebellar ataxia (MSA-C) and those mainly manifesting parkinsonism (MSA-P). Pathophysiological bases of these subtypes remain unclear. We hypothesized that MSA-C patients would resemble spinocerebellar degeneration patients and MSA-P patients would resemble Parkinson's disease (PD) patients in saccade abnormalities.
METHODS: We recorded visually guided and memory guided saccades (MGS) in 27 MSA-C and 15 MSA-P patients, as well as 50 age-matched normal subjects, 14 spinocerebellar degeneration patients showing pure cerebellar symptoms (SCD) and 61 Parkinson's disease (PD) patients.
RESULTS: Saccade parameters of both tasks showed similar changes with progressing disease in SCD and MSA-C patients, as did those of MSA-C and MSA-P patients, although hypometria was slightly more pronounced in MSA-P. In both subtypes of MSA, latency and success rate of MGS were stable throughout disease stages, whereas they deteriorated progressively with progressing disease in PD.
CONCLUSIONS: Pathophysiology underlying MSA-C and MSA-P is similar as viewed from saccade performance. The MGS performance in MSA was preserved. However, MSA-P patients showed more marked hypometria, suggesting a mixture of basal ganglia pathophysiology. SIGNIFICANCE: The similarity of saccade performance between MSA-C and MSA-P may reflect common olivopontocerebellar pathology, while the direct pathway of the basal ganglia is relatively spared compared with PD, even in MSA-P.
Copyright © 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Basal ganglia; Cerebellum; Multiple system atrophy; Parkinson’s disease; Pathophysiology; Saccade

Mesh:

Year:  2015        PMID: 26350408     DOI: 10.1016/j.clinph.2015.07.035

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

Review 1.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

2.  Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram.

Authors:  Yasuo Terao; Hideki Fukuda; Yusuke Sugiyama; Satomi Inomata-Terada; Shin-Ichi Tokushige; Masashi Hamada; Yoshikazu Ugawa
Journal:  J Vis Exp       Date:  2018-03-13       Impact factor: 1.355

3.  How Saccade Intrusions Affect Subsequent Motor and Oculomotor Actions.

Authors:  Yasuo Terao; Hideki Fukuda; Shin-Ichi Tokushige; Satomi Inomata-Terada; Yoshikazu Ugawa
Journal:  Front Neurosci       Date:  2017-01-12       Impact factor: 4.677

Review 4.  What do eye movements tell us about patients with neurological disorders? - An introduction to saccade recording in the clinical setting.

Authors:  Yasuo Terao; Hideki Fukuda; Okihide Hikosaka
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

5.  The Bulbocavernosus Reflex in the Differential Diagnosis of Multiple System Atrophy with Predominant Parkinsonism and Parkinson's Disease.

Authors:  Huan-Jie Huang; Xing-Yu Zhu; Xun Wang; Zhang-Yang Wang; Wan-Li Zhang; Bi-Cheng Chen; Chun-Feng Liu
Journal:  Front Neurol       Date:  2018-01-05       Impact factor: 4.003

6.  Slowed Prosaccades and Increased Antisaccade Errors As a Potential Behavioral Biomarker of Multiple System Atrophy.

Authors:  Sarah H Brooks; Eliana M Klier; Stuart D Red; Neeti D Mehta; Saumil S Patel; Alice Z Chuang; Jessika Suescun; Mya C Schiess; Anne B Sereno
Journal:  Front Neurol       Date:  2017-06-20       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.